Taurolock Hep 500 Versus Unfractionated Heparin as Anti-inflammatory in Hemodialysis Catheters.

• Status: Unknown status
• Trial end date: 2019-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the efficacy of Taurolock-hep500™ as anticoagulant and antimicrobial catheter lock solution in comparison to unfractionated heparin as alock solution to improve performance of hemodialysis catheters and quality of hemodialysis .

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ain Shams University
• Treatments: Calcium heparin; Heparin; Taurolidine

Criteria

Inclusion Criteria:

1. Patients on regular hemodialysis 3sessions/wk.

2. Recent catheter insertion at beginning of the study.

3. Both males and females.

4. Age group ≥ 18 ys.

Exclusion Criteria:

1. Patients with intercurrent infections.

2. Patients with sepsis.

3. Patients receiving drugs affecting immune system like immunosuppressive drugs.

4. Patients on antibiotics.